BioLife Solutions Updates Earnings Call Information

5/8/25 4:32:00 PM ET

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Health Care

Get the next $BLFS alert in real time by email

BOTHELL, Wash., May 8, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ:BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the cell and gene therapy ("CGT") market, is announcing corrected call-in numbers for their Earnings Call this afternoon at 4:30pm ET. If you are joining, please use 1-833-630-0431 if calling from the United States or 1-412-317-1808 if dialing internationally.

About BioLife Solutions

BioLife is a leading developer and supplier of cell processing tools and services for the CGT market. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during the collection, development, manufacturing and distribution. For more information, please visit www.biolifesolutions.com, and follow BioLife on LinkedIn and X.

Media & Investor Relations

At the Company

Troy Wichterman

Chief Financial Officer

(425) 402-1400

[email protected]

Investors

Alliance Advisors IR

Jody Cain

(310) 691-7100

[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-updates-earnings-call-information-302450601.html

SOURCE BioLife Solutions, Inc.

Get the next $BLFS alert in real time by email

Date

Price Target

Rating

Analyst

9/30/2024

$29.00

Buy

H.C. Wainwright

4/4/2024

$22.00

Buy

Jefferies

7/11/2023

$29.00

Buy

Craig Hallum

4/25/2022

$28.00

Perform → Outperform

Oppenheimer

10/19/2021

$61.00

Buy

B. Riley Securities

10/15/2021

$64.00

Outperform

Cowen

8/13/2021

$50.00 → $60.00

Overweight

Keybanc

BioLife Solutions Updates Earnings Call Information

Chat with this insight

Recent Analyst Ratings for
$BLFS

$BLFS
SEC Filings

SEC Form 10-Q filed by BioLife Solutions Inc.

BioLife Solutions Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

Amendment: SEC Form 10-K/A filed by BioLife Solutions Inc.

$BLFS
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Casdin Partners Master Fund, L.P. bought $10,374,976 worth of shares (927,165 units at $11.19) (SEC Form 4)

$BLFS
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Human Resources Officer Aebersold Sarah sold $15,806 worth of shares (711 units at $22.23), decreasing direct ownership by 0.90% to 78,721 units (SEC Form 4)

Large owner Casdin Partners Master Fund, L.P. sold $23,800,000 worth of shares (1,000,000 units at $23.80) (SEC Form 4)

Chief Marketing Officer Berard Todd sold $8,579 worth of shares (362 units at $23.70), decreasing direct ownership by 0.27% to 134,922 units (SEC Form 4)

BioLife Solutions Updates Earnings Call Information

Chat with this insight

Recent Analyst Ratings for $BLFS

$BLFS SEC Filings

SEC Form 10-Q filed by BioLife Solutions Inc.

BioLife Solutions Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

Amendment: SEC Form 10-K/A filed by BioLife Solutions Inc.

$BLFS Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Casdin Partners Master Fund, L.P. bought $10,374,976 worth of shares (927,165 units at $11.19) (SEC Form 4)

$BLFS Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Human Resources Officer Aebersold Sarah sold $15,806 worth of shares (711 units at $22.23), decreasing direct ownership by 0.90% to 78,721 units (SEC Form 4)

Large owner Casdin Partners Master Fund, L.P. sold $23,800,000 worth of shares (1,000,000 units at $23.80) (SEC Form 4)

Chief Marketing Officer Berard Todd sold $8,579 worth of shares (362 units at $23.70), decreasing direct ownership by 0.27% to 134,922 units (SEC Form 4)

Recent Analyst Ratings for
$BLFS

$BLFS
SEC Filings

$BLFS
Insider Purchases

$BLFS
Insider Trading